Ligand validation:7JUR

QOM: Trametinib

QOM is a Ligand Of Interest in 7JUR designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7JUR_QOM_C_402	29%	2%	0.247	0.909	2.75	4.45	15	20	1	0	100%	1
7JUX_QOM_C_402	3%	5%	0.386	0.741	2.4	3.03	12	15	2	0	100%	1
7M0Y_QOM_B_404	28%	4%	0.281	0.934	2.96	3.05	16	22	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.